Company News

As the cannabis and hemp industry grow exponentially, the need for consumer safety is now more important than ever. Supporting that need for product and consumer safety, bioMérieux, a world leader in the field of in vitro diagnostics, received approval from the AOAC Research Institute Performance Tested Methods℠ (PTM) for the detection of Salmonella and STEC (Shiga toxin-producing E. coli) contaminants in cannabis flower and whole hemp flower utilizing GENE-UP® SLM2 (PTM 121802) and EHEC (PTM 121806) assays.

bioMérieux announces the launch of BIOFIRE^® MYCOPLASMA, an innovative test for mycoplasma detection in pharmaceutical products used for biotherapeutics (antibodies, hormones, cell and gene therapies, etc.), the most vibrant sector in the pharmaceutical industry.

bioMérieux announces that its BACT/ALERT^® BPA and BPN culture bottles have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Large Volume Delayed Sampling (LVDS) of leukocyte-reduced apheresis platelets (LRAP) and leukocyte-reduced whole blood platelet concentrates (LRWBPC) with BACT/ALERT^® 3D and BACT/ALERT^® VIRTUO^® systems.